PHASE 2 TRIAL OF NEOADJUVANT AND ADJUVANT PD-1 CHECKPOINT BLOCKADE IN LOCAL-REGIONALLY ADVANCED, RESECTABLE HNSCC INDICATES PATHOLOGICAL RESPONSE IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL

PHASE 2 TRIAL OF NEOADJUVANT AND ADJUVANT PD-1 CHECKPOINT BLOCKADE IN LOCAL-REGIONALLY ADVANCED, RESECTABLE HNSCC INDICATES PATHOLOGICAL RESPONSE IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL Meeting Abstract

Open Access

Wise-Draper, Trisha; Gulati, Shuchi; Takiar, Vinita; Palackdharry, Sarah; Worden, Francis; Old, Matthew; Kaczmar, John; Dunlap, Neal; Hinrichs, Benjamin; Bell, Diana; Patil, Yash; Riaz, Muhammad Kashif; Weatherford, Layne; Hamilton, Aubrey; Lanverman, Sheena; Mierzwa, Michelle; Casper, Keith; Mark, Jonathan; Tang, Alice; Zender, Chad; Gillenwater, Ann; Medvedovich, Mario; Lee, J. Jack; Jandarov, Roman; Gillison, Maura